Pyxis Oncology Stock Forecast

Buy or Hold candidate since Jun 18, 2026 Gain 9.85%

The Pyxis Oncology, Inc. stock price fell by -8.23% on the last day (Thursday, 16th Jul 2026) from $2.43 to $2.23. During the last trading day the stock fluctuated 6.31% from a day low at $2.22 to a day high of $2.36. The price has fallen in 7 of the last 10 days and is down by -21.75% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -98 thousand shares and in total, 414 thousand shares were bought and sold for approximately $922.29 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 29.20% during the next 3 months and, with a 90% probability hold a price between $2.50 and $4.07 at the end of this 3-month period.

PYXS Signals & Forecast

The Pyxis Oncology, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $2.48. On a fall, the stock will find some support from the long-term average at approximately $2.16. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -27.36%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Pyxis Oncology, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.78 and $1.76. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Pyxis Oncology, Inc. finds support just below today's level at $1.78. If this is broken, then the next support from accumulated volume will be at $1.76 and $1.71.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.140 between high and low, or 6.31%. For the last week the stock has had daily average volatility of 9.13%.

Our recommended stop-loss: $2.10 (-6.00%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 7 days ago.)

Trading Expectations (PYXS) For The Upcoming Trading Day Of Friday 17th

For the upcoming trading day on Friday, 17th we expect Pyxis Oncology, Inc. to open at $2.27, and during the day (based on 14 day Average True Range), to move between $2.08 and $2.38, which gives a possible trading interval of +/-$0.301 (+/-14.46%) up or down from last closing price. If Pyxis Oncology, Inc. takes out the full calculated possible swing range there will be an estimated 14.46% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.30 (3.14%) than the support at $1.78 (20.18%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Pyxis Oncology, Inc. stock A Buy?

Pyxis Oncology, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.969 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 17, 2026 - $2.27 ( 1.79%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk